DK3313383T3 - Tyggegummisammensætning til anvendelse til lindring af xerostomi-induceret af strålebehandling - Google Patents
Tyggegummisammensætning til anvendelse til lindring af xerostomi-induceret af strålebehandling Download PDFInfo
- Publication number
- DK3313383T3 DK3313383T3 DK16733400.2T DK16733400T DK3313383T3 DK 3313383 T3 DK3313383 T3 DK 3313383T3 DK 16733400 T DK16733400 T DK 16733400T DK 3313383 T3 DK3313383 T3 DK 3313383T3
- Authority
- DK
- Denmark
- Prior art keywords
- xerostomy
- relief
- induced
- radiation treatment
- gum composition
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
- A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
- A61K9/0058—Chewing gums
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/16—Fluorine compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/02—Inorganic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/24—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing atoms other than carbon, hydrogen, oxygen, halogen, nitrogen or sulfur, e.g. cyclomethicone or phospholipids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/02—Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Epidemiology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Inorganic Chemistry (AREA)
- Molecular Biology (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Zoology (AREA)
- Nutrition Science (AREA)
- Physiology (AREA)
- Biophysics (AREA)
- Biochemistry (AREA)
- Confectionery (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP2015064074 | 2015-06-23 | ||
PCT/EP2016/064578 WO2016207299A1 (en) | 2015-06-23 | 2016-06-23 | Chewing gum composition for use in alleviation of xerostomia induced by radiotherapy treatment |
Publications (1)
Publication Number | Publication Date |
---|---|
DK3313383T3 true DK3313383T3 (da) | 2022-12-12 |
Family
ID=53510843
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DK16733400.2T DK3313383T3 (da) | 2015-06-23 | 2016-06-23 | Tyggegummisammensætning til anvendelse til lindring af xerostomi-induceret af strålebehandling |
Country Status (4)
Country | Link |
---|---|
US (1) | US10695292B2 (da) |
EP (1) | EP3313383B1 (da) |
DK (1) | DK3313383T3 (da) |
WO (1) | WO2016207299A1 (da) |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US11071310B1 (en) * | 2014-12-17 | 2021-07-27 | Natalie Marie Lutz | Oral therapy article, and methods of using same |
Family Cites Families (13)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4241090A (en) * | 1978-12-21 | 1980-12-23 | Life Savers, Inc. | Non-adhesive chewing gums and method |
US4906455A (en) * | 1988-04-15 | 1990-03-06 | Wm. Wrigley Jr. Company | Method for treating xerostomia employing chewing gum containing relatively insoluble, hydrophobic, food-grade organic acid |
US5474787A (en) * | 1994-10-21 | 1995-12-12 | The Wm. Wrigley Jr. Company | Chewing gum containing a lecithin/glycerol triacetate blend |
US5702687A (en) * | 1995-10-03 | 1997-12-30 | Church & Dwight Co., Inc. | Chewing gum product with plaque-inhibiting benefits |
AU2001281749A1 (en) * | 2000-08-14 | 2002-02-25 | Fertin Pharma A/S | Method for preparation of chewing gum with customer acceptable taste |
DE60223659T2 (de) | 2001-03-23 | 2008-10-30 | Gumlink A/S | Einstufiges verfahren zur herstellung von kaugummi |
US20030185884A1 (en) * | 2002-04-01 | 2003-10-02 | Singh Nikhilesh Nihala | Therapeutic agent delivery compositions for buccal cavity absorption of pilocarpine |
WO2004004480A1 (en) * | 2002-07-02 | 2004-01-15 | Gumlink A/S | Compressed resin moderated chewing gum |
EP1495680A1 (en) * | 2003-07-08 | 2005-01-12 | Gum Base Co. S.p.A. | Gum base for chewing gum |
US7776831B2 (en) * | 2006-02-01 | 2010-08-17 | Weg Stuart L | Use of antifungal compositions to treat upper gastrointestinal conditions |
EP1946751A1 (en) | 2007-01-22 | 2008-07-23 | Documedica S.A. | Carrageenan-based chewing gum |
US9730865B2 (en) | 2009-05-22 | 2017-08-15 | Lubris, Llc | Application and uses of PRG4 and therapeutic modulation thereof |
DK2442668T3 (da) * | 2009-06-19 | 2016-12-12 | Fertin Pharma As | Bufret gummibase til høj ph-frigivelse |
-
2016
- 2016-06-23 DK DK16733400.2T patent/DK3313383T3/da active
- 2016-06-23 EP EP16733400.2A patent/EP3313383B1/en active Active
- 2016-06-23 WO PCT/EP2016/064578 patent/WO2016207299A1/en active Application Filing
- 2016-06-23 US US15/735,723 patent/US10695292B2/en active Active
Also Published As
Publication number | Publication date |
---|---|
EP3313383B1 (en) | 2022-10-05 |
EP3313383A1 (en) | 2018-05-02 |
WO2016207299A1 (en) | 2016-12-29 |
US20190060228A1 (en) | 2019-02-28 |
US10695292B2 (en) | 2020-06-30 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DK3431105T3 (da) | Medicinsk sammensætning til behandling af cancer | |
DK3558997T3 (da) | Aminotriazolopyridinforbindelser og deres anvendelse til behandling af cancer | |
DK3377516T3 (da) | Sammensætning til behandling af cancer | |
DK3389778T3 (da) | Indretning til fotodynamisk behandling | |
DK3288581T3 (da) | Fremgangsmåde til behandling af cancer | |
DK3212233T3 (da) | Kombinationsterapi til behandling af sygdom | |
DK3102673T3 (da) | Fremgangsmåder og sammensætninger til behandling af beta-talassæmi | |
DK3119397T3 (da) | Heterocykliske forbindelser til anvendelse i behandling af PI3K-gamma-medierede lidelser | |
DK3212226T3 (da) | Sammensætninger og anvendelsesfremgangsmåder til behandling af metaboliske lidelser | |
DK3851537T3 (da) | Behandling af hyperbilirubinæmi | |
DK3185957T3 (da) | Patisiran til anvendelse ved behandlingen af transthyretin-medieret amyloidosis | |
DK3362066T3 (da) | Kombinationsterapi til behandling af maligniteter | |
DK3102200T3 (da) | Terapeutisk forbindelse og sammensætning | |
DK3882250T3 (da) | Tetrahydropyranyl-amino-pyrrolopyrimidinon til anvendelse i behandling af btk-medierede forstyrrelser | |
DK3261726T3 (da) | Sammensætning til behandling af acne | |
DK3209696T3 (da) | Fremgangsmåder og sammensætninger til diagnosticering og behandling af glioblastom | |
DK3200815T3 (da) | Fremgangsmåder og sammensætninger til behandling af cancer | |
DK2994533T3 (da) | Fremgangsmåder og sammensætninger til behandling af cancer | |
DK3265087T3 (da) | Fremgangsmåde til behandling med tradipitant | |
DK3189074T3 (da) | Sammensætninger og metoder til behandling og forebyggelse af inflammation | |
DK3456330T3 (da) | Cortexolon-17alpha-valerat til anvendelse ved behandling af tumorer | |
DK3110446T3 (da) | Fremgangsmåder og sammensætninger til behandling af Siglec-8-associerede sygdomme | |
DK3213752T3 (da) | Sammensætning til behandling af cancerstamceller | |
DK3391902T3 (da) | Plasminogen til anvendelse i behandlingen af diabetisk angiokardiopati | |
DK3204038T3 (da) | Sammensætninger omfattende amylase til anvendelse i behandlingen af pruritus |